Funds and ETFs Amoy Diagnostics Co., Ltd.

Equities

300685

CNE1000034D3

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
21.55 CNY +2.13% Intraday chart for Amoy Diagnostics Co., Ltd. +2.13% -1.96%

ETFs positioned on Amoy Diagnostics Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +2.14% -
Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Company’s testing reagent products include ADx-ARMS product line for tumor tissue specimen detection, Super-ARMS product line for liquid biopsy, the NGS product line and the FISH product line. The products are used for the detection of non-small cell lung cancer, colorectal cancer, thyroid cancer, melanoma and other malignant tumors. The Company also provides data software to capture and analyze gene sequencing data. The Company provides testing services through its own medical testing institutions, including lung cancer testing, colorectal cancer testing and breast cancer testing.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
21.55 CNY
Average target price
29.55 CNY
Spread / Average Target
+37.11%
Consensus
  1. Stock Market
  2. Equities
  3. 300685 Stock
  4. Funds and ETFs Amoy Diagnostics Co., Ltd.